» Articles » PMID: 26347821

Analysis of Prostate Cancer Susceptibility Variants in South African Men: Replicating Associations on Chromosomes 8q24 and 10q11

Overview
Journal Prostate Cancer
Publisher Wiley
Date 2015 Sep 9
PMID 26347821
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Genome-wide association studies (GWAS) have implicated single nucleotide polymorphisms (SNPs) on chromosomes 2p15, 6q25, 7p15.2, 7q21, 8q24, 10q11, 10q26, 11q13, 17q12, 17q24, 19q13, and Xp11, with prostate cancer (PCa) susceptibility and/or tumour aggressiveness, in populations of African, European, and Asian ancestry. The objective of this study was to confirm these associations in South African Mixed Ancestry and White men. We evaluated 17 prioritised GWAS SNPs in South African cases (331 Mixed Ancestry and 155 White) and controls (178 Mixed Ancestry and 145 White). The replicated SNP associations for the different South African ethnic groups were rs7008482 (8q24) (p = 2.45 × 10(-5)), rs6983267 (8q24) (p = 4.48 × 10(-7)), and rs10993994 (10q11) (p = 1.40 × 10(-3)) in Mixed Ancestry men and rs10993994 (p = 1.56 × 10(-9)) in White men. No significant associations were observed for the analyses stratified by disease aggressiveness in the individual and the combined population group analysis. The present study demonstrates that a number of known PCa susceptibility variants may contribute to disease susceptibility in South African men. Larger genetic investigations extended to other South African population groups are warranted to confirm the role of these and other SNPs in disease susceptibility.

Citing Articles

Review of prostate cancer genomic studies in Africa.

Samtal C, El Jaddaoui I, Hamdi S, Bouguenouch L, Ouldim K, Nejjari C Front Genet. 2022; 13:911101.

PMID: 36303548 PMC: 9593051. DOI: 10.3389/fgene.2022.911101.


Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa.

Kim M, Naidoo D, Hazra U, Quiver M, Chen W, Simonti C Genome Biol. 2022; 23(1):194.

PMID: 36100952 PMC: 9472407. DOI: 10.1186/s13059-022-02766-z.


Prostate Cancer Genomics Research Disparities in Africa: Advancing Knowledge in Resource Constrained Settings.

Fernandez P Cancer Control. 2022; 29:10732748221095952.

PMID: 35475404 PMC: 9087236. DOI: 10.1177/10732748221095952.


The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine.

Lewis D, Cropp C Genes (Basel). 2020; 11(12).

PMID: 33302594 PMC: 7762993. DOI: 10.3390/genes11121471.


A Custom Genotyping Array Reveals Population-Level Heterogeneity for the Genetic Risks of Prostate Cancer and Other Cancers in Africa.

Harlemon M, Ajayi O, Kachambwa P, Kim M, Simonti C, Quiver M Cancer Res. 2020; 80(13):2956-2966.

PMID: 32393663 PMC: 7335354. DOI: 10.1158/0008-5472.CAN-19-2165.


References
1.
Lange E, Johnson A, Wang Y, Zuhlke K, Lu Y, Ribado J . Genome-wide association scan for variants associated with early-onset prostate cancer. PLoS One. 2014; 9(4):e93436. PMC: 3989171. DOI: 10.1371/journal.pone.0093436. View

2.
Gudmundsson J, Sulem P, Manolescu A, Amundadottir L, Gudbjartsson D, Helgason A . Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet. 2007; 39(5):631-7. DOI: 10.1038/ng1999. View

3.
Hooker S, Hernandez W, Chen H, Robbins C, Torres J, Ahaghotu C . Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans. Prostate. 2009; 70(3):270-5. DOI: 10.1002/pros.21061. View

4.
Rebbeck T, Devesa S, Chang B, Bunker C, Cheng I, Cooney K . Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013; 2013:560857. PMC: 3583061. DOI: 10.1155/2013/560857. View

5.
Ni H, Chang Y, Kao P, Chai S, Hsieh Y, Wang D . Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells. Biochim Biophys Acta. 2012; 1820(12):1893-900. DOI: 10.1016/j.bbagen.2012.08.002. View